VENTRITEX FIRST QUARTER 1995 REVENUES UP 62.7% TO $29 MIL., BUT 10% SALES DROP FROM FOURTH QUARTER 1994 REFLECTS MDs' CADENCE/LEAD REIMBURSEMENT ANXIETY
This article was originally published in The Gray Sheet
Executive Summary
Ventritex' first quarter 1995 revenues increased 62.7% over the prior-year period to $29 mil., marching to the beat of growing sales of the firm's Cadence implantable defibrillator. Quarterly earnings were $2.5 mil., turning around the company's $1.8 mil. loss during first quarter 1994.